Interní Med. 2012; 14(5): 195-198

Current views on management of hypertension in patients with diabetes mellitus

MUDr.Josef Macháček
Interní klinika KNTB, a.s. Zlín

Diabetes mellitus and arterial hypertension are risk factors that significantly affect cardiovascular prognosis and prevalence of chronic

renal failure. Their co-occurrence potentiates this risk. The management of hypertension significantly affects these complications. Blood

pressure between 130 and 139 mm Hg has been recommended as target level. RAAS-acting drugs are the mainstay of pharmacological



treatment: It is important to actively search for risk factors, perform screening tests (evaluation of microalbuminuria, the fundus of the

eye, Holter BP) and monitor the therapeutic effect.

Keywords: hypertension, diabetes mellitus, treatment, complications

Published: May 14, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macháček J. Current views on management of hypertension in patients with diabetes mellitus. Interní Med. 2012;14(5):195-198.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713. Go to original source...
    2. Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001; 161: 1183-1192. Go to original source... Go to PubMed...
    3. Charvát J, Kvapil M. Hypertenze u nemocných s diabetes mellitus - Jak ovlivnit kardiovaskulární riziko? Medicína po promoci 2011: 2.
    4. Souček M. Hypertenze u pacienta s diabetes mellitus. Vnitr Lek 2010; 56(Suppl 9): 995-999. Go to PubMed...
    5. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documents. J Hypertens 2009; 27: 2121-2158. Go to original source... Go to PubMed...
    6. Reboldi G, Gentile G, Angeli F, Verdecchia P. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag 2009; 5: 411-427. Go to original source... Go to PubMed...
    7. Ozaki N, Nomura Y, Sobajima H, et al. Comparison of the effects of three angiotensin II receptor type 1 blocker on metabolic parameters in hypertensive patients with type 2 diabetes mellitus. Eur J Intern Med 2010; 21: 236-239. Go to original source... Go to PubMed...
    8. Nissen PM. ACCORD and Risk-Factor Control in Type-2 Diabetes. N Engl J Med 2010; 362: 1628-1630. Go to original source... Go to PubMed...
    9. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61-68. Go to original source... Go to PubMed...
    10. Widimský J. Jaké jsou optimální hodnoty systolického tlaku u diabetiků? Studie ACCORD Blood Pressure dokončena. Cor Vasa 2010; 52: 700-705. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.